SIRT1 activator
This page covers all SIRT1 activator drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting SIRT1.
Targets
Phase 2 pipeline (1)
- ADIPOPLUS · Anterogen Co., Ltd. · Diabetes
ADIPOPLUS is a small molecule that targets the SIRT1 pathway to enhance adipocyte function and glucose metabolism.